Evidence map›Paper›PMID 30763461›Full record

ArticleBJU international2019

Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer: a Cochrane Review.

Niranjan J Sathianathen, Yiannis A Philippou, Gretchen M Kuntz, Badrinath R Konety, Shilpa Gupta, Alastair D Lamb, Philipp Dahm

Abstract readComment
PubMed Publisher
In one paragraph

Article in BJU international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Niranjan J SathianathenDepartment of Urology, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0002-3710-014X
Yiannis A PhilippouNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Gretchen M KuntzBorland Health Sciences Library, University of Florida-Jacksonville, Jacksonville, FL, USA.
Badrinath R KonetyDepartment of Urology, University of Minnesota, Minneapolis, MN, USA.
Shilpa GuptaDivision of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
Alastair D LambNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Philipp DahmDepartment of Urology, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0003-2819-2553

Funding

Cancer Research UK 25812
6 · The paper itself

Abstract

To provide a precis of the Cochrane Collaboration Review of taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer by Sathianathen NJ, Philippou YA, Kuntz GM et al. Cochrane Database of Systematic Reviews 2018, Issue 10. Art. No.: CD012816. https://doi.org/10.1002/14651858.cd012816.pub2.

Indexed as

Prostatic NeoplasmsTaxoidsAndrogen AntagonistsAntineoplastic Combined Chemotherapy ProtocolsHumansMaleAndrogen AntagonistsTaxoidschemotherapymeta-analysis#PCSM#ProstateCancersystematic review

Identifiers

PMID30763461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.